Prevalence and predictors of premature discontinuation of dual antiplatelet therapy after drug-eluting stent implantation: Importance of social factors in Asian patients

Internal Medicine Journal

Volumn 41, Issue 8, 2011, Pages 623-629

  Poh, C L ^a   Chan, M Y ^a   Lau, C ^a   Teo, S G ^a   Low, A F ^a   Tan, H C ^a   Lee, Chi Hang ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Antiplatelet therapy; Drug eluting stents; Stent thrombosis and compliance

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ALLERGY; ARTICLE; ASIAN; BLEEDING; DRUG ELUTING STENT; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOCIAL ASPECT; STOMACH DISCOMFORT;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES; SOCIAL ENVIRONMENT;

EID: 78650316267     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02104.x     Document Type: Article

References (17)

1. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT etal. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-31.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C etal.; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
3. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC etal. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008.
4. Flores-Ríos X, Marzoa-Rivas R, Abugattás-de Torres JP, Piñón-Esteban P, Aldama-López G, Salgado-Fernández J etal. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients. Am Heart J 2008; 155: 648-53.
5. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G etal. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-30.
6. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC etal. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113: 1108-13.
7. Artang R, Dieter RS. Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries. Am J Cardiol 2007; 99: 1039-43.
8. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ etal.; American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115: 813-18.
9. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS etal. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006; 113: 2803-9.
10. Latib A, Morici N, Cosgrave J, Airoldi F, Godino C, Brambilla N etal. Incidence of bleeding and compliance on prolonged dual antiplatelet therapy (aspirin + thienopyridine) following drug-eluting stent implantation. Am J Cardiol 2008; 102: 1477-81.
11. Park SJ, Kim YH. Current status of percutaneous coronary intervention with drug-eluting stents in Asia. Circulation 2008; 118: 2730-7.
12. Iwata Y, Kobayashi Y, Fukushima K, Kitahara H, Asano T, Ishio N etal. Incidence of premature discontinuation of antiplatelet therapy after sirolimus-eluting stent implantation. Circ J 2008; 72: 340-1.
13. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA etal.; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115: 2344-51.
14. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006; 119: 1056-61.
15. Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K etal. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45:947-53.
16. Baran KW, Lasala JM, Cox DA, Song A, Deshpande MC, Jacoski MV etal.; ARRIVE Investigators. A clinical risk score for prediction of stent thrombosis. Am J Cardiol 2008; 102: 541-5.
17. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB etal. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-68.